After treatment with TPP‐LND@Lip combined with radiotherapy, tumor weight was decreased by 66.6 ± 10.4%, while in the PD‐L1 monoclonal antibody with radiotherapy group, tumor weight was only decreased by 54.7 ± 23.6% (Figure 8D). Here, CD274 is linked to neoplasm.